Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)Hans‐Joachim Schmoll, Eric Van Cutsem, Ilona Kocáková et al.|Journal of Clinical Oncology|2012Cited by 210
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal CancerMichael P. Chu, Michael B. Sawyer, J. Randolph Hecht et al.|JAMA Oncology|2016Cited by 106
LAPACT: An open-label, multicenter phase II trial of <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC).Philip Agop Philip, Pascal Hammel, Jill Lacy et al.|Journal of Clinical Oncology|2016Cited by 3